U.S. Stem Cell
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of U.S. Stem Cell generated cash of -$304,852, which is more than the previous year. Cash used in financing activities reached the amount of $270,592 last year. Net change in cash is therefore -$34,260.
Cash Flow
| 2013 | -1.91M | -9.42K | 1.96M |
|---|---|---|---|
| 2014 | -1.10M | -57.83K | 1.15M |
| 2015 | -844.69K | -234.03K | 1.10M |
| 2016 | 112.24K | 155.10K | -54.99K |
| 2017 | 1.23M | 723.83K | -1.23M |
| 2018 | 602.46K | 311.7K | -543.82K |
| 2019 | -1.21M | 166.83K | -312.98K |
| 2020 | -478.88K | 0 | 497.45K |
| 2021 | -1.05M | 0 | 1.07M |
| 2022 | -304.85K | 0 | 270.59K |
USRM Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 39.39K | 18.57K | 0 | 1.35M | 986.79K | 270.72K | 58.37K | 36.67K | 46.22K | 0 |
Operating activities | ||||||||||
Net income | -2.85M | -3.28M | -2.89M | -3.83M | -2.16M | -3.48M | -2.07M | -1.64M | -2.25M | -3.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 977.38K | 447.38K | 242.61K | 207.13K | 178.74K | 5.78K | 5.32K | 4.49K | 2.19K |
Stock-based compensation expense | 384.38K | 556.55K | 701.93K | 824.42K | 0 | 645.48K | 410.00K | 1.15M | 537.60K | 125.51K |
| Deferred income tax benefit | 384.38K | 556.55K | 701.93K | 824.42K | 0 | 645.48K | 410.00K | 1.15M | 537.60K | 125.51K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.73K | -40.29K | -5.95K | -76.29K | -37.28K | -43.67K | 13.36K | 21.77K | -104.22K | 0 |
Inventories | -587 | 5.02K | 2.67K | 85.11K | -22.85K | -28.14K | -24.81K | -17.40K | 104.22K | 62.95K |
Accounts payable | 274.26K | 73.19K | 149.52K | 344.53K | 426.26K | 469.22K | 10.46K | 434.49K | 858.43K | -59.05K |
Cash generated by operating activities | -304.85K | -1.05M | -478.88K | -1.21M | 602.46K | 1.23M | 112.24K | -844.69K | -1.10M | -1.91M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 15.26K | 189.90K | 0 | 0 | -10K | -49.71K | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | -166.83K | 0 | -1.16K | -12.58K | -2.03K | -8.12K | -9.42K |
Acquisitions Net | 0 | 0 | 0 | 166.83K | 311.7K | 225K | 500 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 166.83K | 311.7K | 723.83K | 155.10K | -234.03K | -57.83K | -9.42K |
Financing activities | ||||||||||
Common Stock Issued | 85K | 275K | 0 | 50K | 0 | 275K | 60K | 582.80K | 479.62K | 1.42M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -7 | 0 | 0 | 0 |
Repayments of term debt | -17.61K | -52.23K | -47.23K | -427.61K | -436.25K | -1.51M | -653.08K | 504.00K | -232.95K | -88.84K |
Cash used in financing activities | 270.59K | 1.07M | 497.45K | -312.98K | -543.82K | -1.23M | -54.99K | 1.10M | 1.15M | 1.96M |
Net Change In Cash | -34.26K | 20.82K | 18.57K | -1.35M | 370.34K | 716.07K | 212.34K | 21.69K | -9.55K | 46.22K |
Cash at end of period | 5.13K | 39.39K | 18.57K | 0 | 1.35M | 986.79K | 270.72K | 58.37K | 36.67K | 46.22K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |